Allan Moss backs Atomo diagnostics
Atomo, which was established in 2010, has developed a platform aimed at enabling quick and affordable point-of-care and consumer diagnostics.
"Atomo has developed a remarkably user-friendly and accurate testing device which has the potential to assist greatly in detecting HIV and other diseases in Africa and globally," Mr Moss said in a statement.
Remember Anteo's work with Atomo announced recently in June 2016:
"Anteo is pleased to announce that it will partner with Sydney-based Atomo Diagnostics to develop a clinical prototype of a cost effective and accurate point of care test for the diagnosis of heart attacks."
ADO Price at posting:
5.9¢ Sentiment: Buy Disclosure: Held
